Avian ("Bird") Flu Stocks Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Avian ("Bird") Flu Stocks

NNVC 1.850

-2.6%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: DewDiligence_on_SI	11/4/2005 9:45:30 PM
	Read Replies (2) of 428

LMAO… Note how HEB waits until after the close to issue this correction: biz.yahoo.com >> Ampligen(R) Currently Administered to 750 'Very Ill' Patients Annually Friday November 4, 4:27 pm ET PHILADELPHIA--(BUSINESS WIRE)--Nov. 4, 2005--Hemispherx Biopharma, Inc. (AMEX: HEB ) today reported that it has come to the Company's attention that a CNN Money report entitled "New Drug said to triple Tamilfu supply" dated November 2, 2005 incorrectly states that Ampligen® is currently administered to 75,000 "very ill" patients annually, whereas the actual number is 750 patients annually. <<

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next